Beliefs about Hydroxyurea (cas 127-07-1) in youth with sickle cell disease
-
Add time:09/10/2019 Source:sciencedirect.com
BackgroundHydroxyurea (cas 127-07-1) reduces complications and improves health-related quality of life (HRQOL) in sickle cell disease (SCD) patients, however adherence remains suboptimal. Understanding patients’ views of hydroxyurea is critical to optimize adherence, particularly in adolescents and young adults (AYA). Study objectives were to assess beliefs about hydroxyurea using the Beliefs about Medicines Questionnaire (BMQ), and to examine the relationship of patients’ beliefs to their hydroxyurea adherence and HRQOL.
We also recommend Trading Suppliers and Manufacturers of Hydroxyurea (cas 127-07-1). Pls Click Website Link as below: cas 127-07-1 suppliers
Prev:Original ArticlesTargeted Hydroxyurea (cas 127-07-1) Education after an Emergency Department Visit Increases Hydroxyurea (cas 127-07-1) Use in Children with Sickle Cell Anemia
Next:Hydroxyurea (cas 127-07-1) embryotoxicity is enhanced in P53-deficient mice) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical studyCutaneous ulcers associated with Hydroxyurea (cas 127-07-1) therapy09/30/2019
- Real-life experience with Hydroxyurea (cas 127-07-1) in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent09/29/2019
- Case StudyMalleolar Ulceration Induced by Hydroxyurea (cas 127-07-1) Therapy for Chronic Eosinophila09/28/2019
- Acute Hydroxyurea (cas 127-07-1) treatment reduces tubular damage following bilateral ischemia-reperfusion injury in a mouse model of sickle cell disease10/01/2019
- Optimising genetic transformation of Trypanosoma cruzi using Hydroxyurea (cas 127-07-1)-induced cell-cycle synchronisation09/27/2019
- p53 mediates Hydroxyurea (cas 127-07-1) resistance in aneuploid cells of colon cancer09/26/2019
- Hydroxyurea (cas 127-07-1): Analytical techniques and quantitative analysis09/25/2019
- Hydroxyurea (cas 127-07-1) embryotoxicity is enhanced in P53-deficient mice09/24/2019
- Original ArticlesTargeted Hydroxyurea (cas 127-07-1) Education after an Emergency Department Visit Increases Hydroxyurea (cas 127-07-1) Use in Children with Sickle Cell Anemia09/09/2019